Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Dang

Showing results (501-510 of 528) with videos related to

Pageof 53
Sort By:
Chembiochem : a European Journal of Chemical Biology|August 21, 2020
Fungal Epithiodiketopiperazines Carrying α,β-Polysulfide Bridges from Penicillium steckii YE, and Their Chemical InterconversionGuangde Jiang, Peilan Zhang, Ranjala Ratnayake, et al.
Biomarker Research|March 24, 2021
Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibodyYutaro Kaneko, Ryo Hatano, Naoto Hirota, et al.
Biomaterials|July 17, 2017
Hyperactive FOXO1 results in lack of tip stalk identity and deficient microvascular regeneration during kidney injuryLan T H Dang, Takahide Aburatani, Graham A Marsh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2024
Randomized Trial of Patient Outreach Approaches to De-implement Outdated Colonoscopy Surveillance IntervalsJeffrey K Lee, Pradeep C Koripella, Christopher D Jensen, et al.
Applied and Environmental Microbiology|June 11, 2026
Polyclonal emergence of virulent, multidrug-resistant <i>Edwardsiella tarda</i> lineages associated with bacillary necrosis of <i>Pangasius</i> in striped catfish farmsTrong-Tuong Ho, Phung-Hieu Diep, Vinh Q Tu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2013
Safety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximabLuis Fayad, Fritz Offner, Mitchell R Smith, et al.
Leukemia & Lymphoma|April 11, 2014
Phase 1/2 study of ocaratuzumab, an Fc-engineered humanized anti-CD20 monoclonal antibody, in low-affinity FcγRIIIa patients with previously treated follicular lymphomaKristen N Ganjoo, Sven de Vos, Brad L Pohlman, et al.
Tropical Medicine & International Health : TM & IH|February 16, 2025
An mHealth app technology to strengthen adverse event management of multi-drug-resistant tuberculosis in Vietnam: Protocol for a process evaluation of the V-SMART trialBinh Hoa Nguyen, Tho T H Dang, Duy Trinh Hoang, et al.
Human Brain Mapping|July 5, 2019
The joint effect of aging and HIV infection on microstructure of white matter bundlesTaylor Kuhn, Yan Jin, Chao Huang, et al.
Journal of the International AIDS Society|July 24, 2018
From conventional to disruptive: upturning the HIV testing status quo among men who have sex with men in VietnamKimberly E Green, Bao N Vu, Huong Tt Phan, et al.
Pageof 53

Showing results (501-510 of 528) with videos related to

Sort By:
Pageof 53
Chembiochem : a European Journal of Chemical Biology|August 21, 2020
Fungal Epithiodiketopiperazines Carrying α,β-Polysulfide Bridges from Penicillium steckii YE, and Their Chemical InterconversionGuangde Jiang, Peilan Zhang, Ranjala Ratnayake, et al.
Biomarker Research|March 24, 2021
Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibodyYutaro Kaneko, Ryo Hatano, Naoto Hirota, et al.
Biomaterials|July 17, 2017
Hyperactive FOXO1 results in lack of tip stalk identity and deficient microvascular regeneration during kidney injuryLan T H Dang, Takahide Aburatani, Graham A Marsh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2024
Randomized Trial of Patient Outreach Approaches to De-implement Outdated Colonoscopy Surveillance IntervalsJeffrey K Lee, Pradeep C Koripella, Christopher D Jensen, et al.
Applied and Environmental Microbiology|June 11, 2026
Polyclonal emergence of virulent, multidrug-resistant <i>Edwardsiella tarda</i> lineages associated with bacillary necrosis of <i>Pangasius</i> in striped catfish farmsTrong-Tuong Ho, Phung-Hieu Diep, Vinh Q Tu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2013
Safety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximabLuis Fayad, Fritz Offner, Mitchell R Smith, et al.
Leukemia & Lymphoma|April 11, 2014
Phase 1/2 study of ocaratuzumab, an Fc-engineered humanized anti-CD20 monoclonal antibody, in low-affinity FcγRIIIa patients with previously treated follicular lymphomaKristen N Ganjoo, Sven de Vos, Brad L Pohlman, et al.
Tropical Medicine & International Health : TM & IH|February 16, 2025
An mHealth app technology to strengthen adverse event management of multi-drug-resistant tuberculosis in Vietnam: Protocol for a process evaluation of the V-SMART trialBinh Hoa Nguyen, Tho T H Dang, Duy Trinh Hoang, et al.
Human Brain Mapping|July 5, 2019
The joint effect of aging and HIV infection on microstructure of white matter bundlesTaylor Kuhn, Yan Jin, Chao Huang, et al.
Journal of the International AIDS Society|July 24, 2018
From conventional to disruptive: upturning the HIV testing status quo among men who have sex with men in VietnamKimberly E Green, Bao N Vu, Huong Tt Phan, et al.
Pageof 53